Research ArticleExperimental Studies
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy
MASATAKA ONEYAMA, NAOYA SAKAMOTO, NAOHIDE OUE, YAYOI KIMURA, YUKIHIKO HIROSHIMA, ITARU HASHIMOTO, KENTARO HARA, YUKIO MAEZAWA, KAZUKI KANO, TORU AOYAMA, HIROHITO FUJIKAWA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, HARUHIKO CHO, HIROYUKI ITO, NORIO YUKAWA, MANABU SHIOZAWA, TAKAKI YOSHIKAWA, SOICHIRO MORINAGA, YASUSHI RINO, MUNETAKA MASUDA, YOHEI MIYAGI, WATARU YASUI and TAKASHI OSHIMA
Anticancer Research December 2019, 39 (12) 6567-6573; DOI: https://doi.org/10.21873/anticanres.13872
MASATAKA ONEYAMA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
2Department of Surgery, Yokohama City University, Yokohama, Japan
NAOYA SAKAMOTO
3Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Science, Hiroshima, Japan
NAOHIDE OUE
3Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Science, Hiroshima, Japan
YAYOI KIMURA
4Advanced Medical Research Center, Yokohama City University, Yokohama, Japan
YUKIHIKO HIROSHIMA
5Kanagawa Cancer Center Research Institute, Yokohama, Japan
ITARU HASHIMOTO
2Department of Surgery, Yokohama City University, Yokohama, Japan
KENTARO HARA
2Department of Surgery, Yokohama City University, Yokohama, Japan
YUKIO MAEZAWA
6Department of Surgery, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
KAZUKI KANO
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
TORU AOYAMA
2Department of Surgery, Yokohama City University, Yokohama, Japan
HIROHITO FUJIKAWA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
TAKANOBU YAMADA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
HIROSHI TAMAGAWA
2Department of Surgery, Yokohama City University, Yokohama, Japan
NAOTO YAMAMOTO
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
TAKASHI OGATA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
HARUHIKO CHO
6Department of Surgery, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
HIROYUKI ITO
7Department of Respiratory Surgery, Kanagawa Cancer Center, Yokohama, Japan
NORIO YUKAWA
2Department of Surgery, Yokohama City University, Yokohama, Japan
MANABU SHIOZAWA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
TAKAKI YOSHIKAWA
8Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
SOICHIRO MORINAGA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
YASUSHI RINO
2Department of Surgery, Yokohama City University, Yokohama, Japan
MUNETAKA MASUDA
2Department of Surgery, Yokohama City University, Yokohama, Japan
YOHEI MIYAGI
5Kanagawa Cancer Center Research Institute, Yokohama, Japan
WATARU YASUI
3Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Science, Hiroshima, Japan
TAKASHI OSHIMA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
In this issue
Anticancer Research
Vol. 39, Issue 12
December 2019
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy
MASATAKA ONEYAMA, NAOYA SAKAMOTO, NAOHIDE OUE, YAYOI KIMURA, YUKIHIKO HIROSHIMA, ITARU HASHIMOTO, KENTARO HARA, YUKIO MAEZAWA, KAZUKI KANO, TORU AOYAMA, HIROHITO FUJIKAWA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, HARUHIKO CHO, HIROYUKI ITO, NORIO YUKAWA, MANABU SHIOZAWA, TAKAKI YOSHIKAWA, SOICHIRO MORINAGA, YASUSHI RINO, MUNETAKA MASUDA, YOHEI MIYAGI, WATARU YASUI, TAKASHI OSHIMA
Anticancer Research Dec 2019, 39 (12) 6567-6573; DOI: 10.21873/anticanres.13872
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy
MASATAKA ONEYAMA, NAOYA SAKAMOTO, NAOHIDE OUE, YAYOI KIMURA, YUKIHIKO HIROSHIMA, ITARU HASHIMOTO, KENTARO HARA, YUKIO MAEZAWA, KAZUKI KANO, TORU AOYAMA, HIROHITO FUJIKAWA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, HARUHIKO CHO, HIROYUKI ITO, NORIO YUKAWA, MANABU SHIOZAWA, TAKAKI YOSHIKAWA, SOICHIRO MORINAGA, YASUSHI RINO, MUNETAKA MASUDA, YOHEI MIYAGI, WATARU YASUI, TAKASHI OSHIMA
Anticancer Research Dec 2019, 39 (12) 6567-6573; DOI: 10.21873/anticanres.13872
Jump to section
Related Articles
- No related articles found.
Cited By...
- Clinical Significance of Tryptophanyl-tRNA Synthetase 1 Gene Expression in Patients With Locally Advanced Gastric Cancer
- Clinical Significance of Chitinase-3-like Protein 1 Gene Expression in Patients With Locally Advanced Gastric Cancer
- Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced Gastric Cancer After Curative Resection
- Clinical Significance of Pregnancy Zone Protein Expression in Patients With Locally Advanced Gastric Cancer After Curative Resection